生物標記發現外包服務市場,份額,規模,趨勢,行業分析報告:按類型,治療領域,發現階段,最終用途,地區,細分市場,預測2023-2032 年

根據 Polaris Market Research 的一項新研究，到 2032 年，全球生物標記發現外包服務的市場規模預計將達到 704.4 億美元。該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

生物標記在臨床試驗中的使用不斷增加，製藥公司對生物標記研究服務外包的需求也增加。此外，製藥業外包各個方面的業務（包括生物標記研究）的趨勢日益明顯，有助於市場擴張。同樣受到推動的是液體活檢的日益普及，這是一種分析血液、尿液和腦脊髓液等體液中生物標記的技術。液體活檢的優點是比傳統組織活檢侵入性更小，並且可以即時提供資訊。隨著液體活檢的普及，對生物標記發現外包服務的需求也在增加，成為市場成長的關鍵因素。

由於藥物開發和臨床試驗的增加，市場正在經歷顯著成長。生物標記在藥物開發中已變得至關重要，可幫助製藥公司確定適當的藥物標靶、簡化臨床試驗程序並確定適當的患者群體進行測試。Masu。截至2023年，全球臨床試驗狀況如下：在ClinicalTrials.gov註冊了452,604項臨床試驗，有64,838名活躍參與者。與 2021 年初約 365,000 項註冊試驗相比，這一數字顯著增加，凸顯了臨床研究領域的強勁和持續擴張。

生物標誌物發現的未來在很大程度上依賴於組學技術的進步。基因組學、蛋白質組學、代謝組學和其他組學領域的重大進展使科學家能夠識別新的生物標記。整合這些不同組學領域的數據對於生物標記識別非常有益。透過結合基因組學、蛋白質組學和代謝組學的見解，研究人員可以獲得對複雜疾病的全面了解。

專門從事多組學資料整合的外包服務在此過程中發揮關鍵作用。這些專業服務提供者擁有駕馭不同組學數據的複雜性並有效整合它們的專業知識。透過將生物標記發現外包給這些專家，製藥公司和研究機構可以利用最新的技術和方法來識別創新的生物標記物，這對於推進醫療保健領域的診斷和研究方法至關重要。

生物標誌物發現外包服務市場報告亮點

替代終點主導市場，因為它們提供了對藥物作用機制的精確理解，為個人化治療鋪平了道路。

由於癌症患者數量的增加和癌症研究的投資，腫瘤學將佔據最大的市場份額

北美由於其龐大的工業學術網絡、研究資金和參與計算生物學的主要公司而佔據了市場主導地位。

主要市場參與者包括Laboratory Corporation of America、Charles River Laboratories、Eurofins Scientific、Celerion、ICON、Parexel、Proteome Sciences等。

目錄

第一章簡介

第二章執行摘要

第三章研究方法論

第四章全球生物標記發現外包服務市場洞察

• 生物標記檢測外包服務 - 產業概況
• 生物標記發現外包服務市場動態
  • 驅動因素和機遇
    • 日益關注個人化醫療和標靶治療
    • 高通量組學技術的進展
  • 限制因素和挑戰
    • 對生物標記驗證和臨床實用性的了解有限
• PESTLE分析
• 生物標誌物發現外包服務的產業趨勢
• 價值鏈分析
• COVID-19 感染的影響分析

第五章全球生物標記發現外包服務市場（依治療領域）

• 主要發現
• 介紹
• 腫瘤學
• 神經病學
• 心臟病學
• 自身免疫性疾病
• 其他

第六章全球生物標記發現外包服務市場（按類型）

• 主要發現
• 介紹
• 預測性生物標記
• 預後生物標記
• 安全生物標記
• 替代終點

第七章全球生物標記發現外包服務市場（依發現階段）

• 主要發現
• 介紹
• 生物標記鑑定
• 生物標記驗證
• 生物標記分析
• 生物標記組合開發
• 生物標誌物選擇

第八章全球生物標記發現外包服務市場（按最終用途）

• 主要發現
• 介紹
• 製藥公司
• 生物技術公司
• 其他

第九章全球生物標記發現外包服務市場（按地區）

• 主要發現
• 介紹
  • 生物標記發現外包服務市場評估，地區，2019-2032
• 生物標誌發現外包服務市場—北美
  • 北美：2019-2032 年按治療領域劃分的生物標記發現外包服務市場
  • 北美：生物標記發現外包服務市場（按最終用途），2019-2032 年
  • 北美：2019-2032 年生物標記發現外包服務市場（按類型）
  • 北美：生物標記發現外包服務市場，按發現階段劃分，2019-2032 年
  • 生物標記發現外包服務市場—美國
  • 生物標誌發現外包服務市場—加拿大
• 生物標記發現外包服務市場 - 歐洲
  • 歐洲：2019-2032 年生物標記發現外包服務市場（依治療領域）
  • 歐洲：生物標記發現外包服務市場（按最終用途），2019-2032 年
  • 歐洲：2019-2032 年生物標記發現外包服務市場（按類型）
  • 歐洲：生物標記物發現外包服務市場，依發現階段劃分，2019-2032 年
  • 生物標記發現外包服務市場 - 英國
  • 生物標誌發現外包服務市場—法國
  • 生物標誌發現外包服務市場—德國
  • 生物標誌發現外包服務市場—義大利
  • 生物標誌發現外包服務市場—西班牙
  • 生物標記發現外包服務市場—荷蘭
  • 生物標誌發現外包服務市場—俄羅斯
• 生物標記發現外包服務市場 - 亞太地區
  • 亞太地區：2019-2032 年生物標記發現外包服務市場（依治療領域）
  • 亞太地區：2019-2032 年生物標記物發現外包服務市場（依最終用途）
  • 亞太地區：2019-2032 年生物標記發現外包服務市場（按類型）
  • 亞太地區：生物標記物發現外包服務市場，依發現階段劃分，2019-2032 年
  • 生物標誌發現外包服務市場 - 中國
  • 生物標誌發現外包服務市場—印度
  • 生物標誌發現外包服務市場—日本
  • 生物標誌發現外包服務市場 - 馬來西亞
  • 生物標誌發現外包服務市場—印度尼西亞
  • 生物標誌發現外包服務市場—韓國
• 生物標記發現外包服務市場—中東和非洲
  • 中東和非洲：2019-2032 年按治療領域劃分的生物標記發現外包服務市場
  • 中東和非洲：2019-2032 年生物標記物發現外包服務市場（以最終用途）
  • 中東和非洲：2019-2032 年生物標記發現外包服務市場（按類型）
  • 中東和非洲：生物標記物發現外包服務市場，按發現階段劃分，2019-2032 年
  • 生物標誌物發現外包服務市場 - 沙烏地阿拉伯
  • 生物標記發現外包服務市場—南非
  • 生物標記發現外包服務市場 - 以色列
  • 生物標誌發現外包服務市場—阿拉伯聯合大公國
• 生物標記發現外包服務市場 - 拉丁美洲
  • 拉丁美洲：2019-2032 年按治療領域劃分的生物標記發現外包服務市場
  • 拉丁美洲：生物標記發現外包服務市場（按最終用途），2019-2032 年
  • 拉丁美洲：2019-2032 年生物標記發現外包服務市場（按類型）
  • 拉丁美洲：生物標記物發現外包服務市場，按發現階段劃分，2019-2032 年
  • 生物標誌發現外包服務市場—墨西哥
  • 生物標誌發現外包服務市場—巴西
  • 生物標誌發現外包服務市場—阿根廷

第10章競爭格局

• 擴張和收購分析
  • 擴張
  • 獲得
• 夥伴關係/協作/協議/揭露

第十一章公司簡介

• Laboratory Corporation of America Holdings
• Charles River Laboratories
• Eurofins Scientific
• Celerion
• ICON plc
• Parexel International（MA）Corporation
• Proteome Sciences
• GHO Capital
• Thermo Fisher Scientific Inc.
• Evotec

The global biomarker discovery outsourcing services market size is expected to reach USD 70.44 billion by 2032, according to a new study by Polaris Market Research. The report "Biomarker Discovery Outsourcing Services Market Share, Size, Trends, Industry Analysis Report, By Type; By Therapeutic Area (Oncology, Neurology, Cardiology, Autoimmune Diseases, Others); By Discovery Phase; By End-use; By Region, And Segment Forecasts, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Rising use of biomarkers in clinical trials, leading to an increased demand for outsourced biomarker research services by pharmaceutical companies. Additionally, the pharmaceutical industry is increasingly outsourcing various aspects of its operations, including biomarker research, contributing to the market's expansion. Another driving force is the growing adoption of liquid biopsies, a technique that involves analyzing biomarkers in bodily fluids like blood, urine, and cerebrospinal fluid. Liquid biopsies offer advantages over traditional tissue biopsies, being less invasive and providing real-time information. As the popularity of liquid biopsies rises, the demand for biomarker discovery outsourcing services is also increasing, making it a pivotal factor in the market's growth.

The market is experiencing significant growth due to the rise in drug development and clinical trials. Biomarkers have become pivotal in drug development, aiding pharmaceutical companies in pinpointing appropriate drug targets, streamlining clinical trial procedures, and identifying suitable patient populations for trials. As of 2023, the global clinical trial landscape boasts an impressive 452,604 registered trials on ClinicalTrials.gov, with 64,838 actively enrolling participants. This marks a substantial increase compared to the approximately 365,000 registered trials noted in early 2021, highlighting the robust and continuous expansion within the realm of clinical research.

The future of biomarker discovery is heavily reliant on advancements in omics technologies. Genomics, proteomics, metabolomics, and other omics disciplines have made significant progress, allowing scientists to identify new biomarkers. Integrating data from these various omics fields is incredibly beneficial for biomarker identification. By combining insights from genomics, proteomics, and metabolomics, researchers can gain a comprehensive understanding of complex disorders.

Outsourcing services that specialize in multi-omics data integration play a crucial role in this process. These specialized service providers have the expertise to navigate the complexities of different omics data and integrate them effectively. By outsourcing biomarker discovery efforts to these experts, pharmaceutical companies and research institutions can leverage the latest technologies and methodologies, leading to the identification of innovative biomarkers essential for advancing diagnostics and therapeutics in the field of healthcare.

Biomarker Discovery and Outsourcing Services Market Report Highlights

Surrogate endpoints dominated the market, as they precise drug's mechanism of action, paving the way for personalized therapies.

The oncology segment held the largest share, owing to rising cases of cancer and investments in cancer research

North America dominated the market, as it possesses a huge industry-academia network, the presence of research funding, and key companies involved in computational biology

The key market players include Laboratory Corporation of America, Charles River Laboratories, Eurofins Scientific, Celerion, ICON, Parexel, and Proteome Sciences

Polaris Market Research has segmented the biomarker discovery and outsourcing services market report based on type, therapeutic area, discovery phase, end use, and region:

Biomarker Discovery and Outsourcing Services, Type Outlook (Revenue - USD Billion, 2019 - 2032)

• Predictive biomarkers
• Prognostic biomarkers
• Safety biomarkers
• Surrogate endpoints

Biomarker Discovery and Outsourcing Services, Therapeutic Area Outlook (Revenue - USD Billion, 2019 - 2032)

• Oncology
• Neurology
• Cardiology
• Autoimmune Diseases
• Others

Biomarker Discovery and Outsourcing Services, Discovery Phase Outlook (Revenue - USD Billion, 2019 - 2032)

• Biomarker Identification
• Biomarker Validation
• Biomarker Profiling
• Biomarker Panel Development
• Biomarker Selection

Biomarker Discovery and Outsourcing Services, End Use Outlook (Revenue - USD Billion, 2019 - 2032)

• Pharmaceutical Companies
• Biotechnology Companies
• Others

Biomarker Discovery and Outsourcing Services, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Latin America
• Argentina
• Brazil
• Mexico
• Middle East & Africa
• UAE
• Saudi Arabia
• Israel
• South Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Biomarker Discovery Outsourcing Services Market Insights

• 4.1. Biomarker Discovery Outsourcing Services - Industry Snapshot
• 4.2. Biomarker Discovery Outsourcing Services Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Increasing focus on personalized medicine and targeted therapies
    • 4.2.1.2. Advancements in high-throughput omics technologies
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. limited understanding of biomarker validation and clinical utility
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTLE Analysis
• 4.5. Biomarker Discovery Outsourcing Services Industry Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
• 5.3. Oncology
  • 5.3.1. Global Biomarker Discovery Outsourcing Services Market, by Oncology, by Region, 2019-2032 (USD Billion)
• 5.4. Neurology
  • 5.4.1. Global Biomarker Discovery Outsourcing Services Market, by Neurology, by Region, 2019-2032 (USD Billion)
• 5.5. Cardiology
  • 5.5.1. Global Biomarker Discovery Outsourcing Services Market, by Cardiology, by Region, 2019-2032 (USD Billion)
• 5.6. Autoimmune Diseases
  • 5.6.1. Global Biomarker Discovery Outsourcing Services Market, by Autoimmune Diseases, by Region, 2019-2032 (USD Billion)
• 5.7. Others
  • 5.7.1. Global Biomarker Discovery Outsourcing Services Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Biomarker Discovery Outsourcing Services Market, by Type

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
• 6.3. Predictive biomarkers
  • 6.3.1. Global Biomarker Discovery Outsourcing Services Market, by Predictive biomarkers, by Region, 2019-2032 (USD Billion)
• 6.4. Prognostic biomarkers
  • 6.4.1. Global Biomarker Discovery Outsourcing Services Market, by Prognostic biomarkers, by Region, 2019-2032 (USD Billion)
• 6.5. Safety biomarkers
  • 6.5.1. Global Biomarker Discovery Outsourcing Services Market, by Safety biomarkers, by Region, 2019-2032 (USD Billion)
• 6.6. Surrogate endpoints
  • 6.6.1. Global Biomarker Discovery Outsourcing Services Market, by Surrogate endpoints, by Region, 2019-2032 (USD Billion)

7. Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• 7.3. Biomarker Identification
  • 7.3.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Identification, by Region, 2019-2032 (USD Billion)
• 7.4. Biomarker Validation
  • 7.4.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Validation, by Region, 2019-2032 (USD Billion)
• 7.5. Biomarker Profiling
  • 7.5.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Profiling, by Region, 2019-2032 (USD Billion)
• 7.6. Biomarker Panel Development
  • 7.6.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Panel Development, by Region, 2019-2032 (USD Billion)
• 7.7. Biomarker Selection
  • 7.7.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Selection, by Region, 2019-2032 (USD Billion)

8. Global Biomarker Discovery Outsourcing Services Market, by End Use

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
• 8.3. Pharmaceutical Companies
  • 8.3.1. Global Biomarker Discovery Outsourcing Services Market, by Pharmaceutical Companies, by Region, 2019-2032 (USD Billion)
• 8.4. Biotechnology Companies
  • 8.4.1. Global Biomarker Discovery Outsourcing Services Market, by Biotechnology Companies, by Region, 2019-2032 (USD Billion)
• 8.5. Others
  • 8.5.1. Global Biomarker Discovery Outsourcing Services Market, by Others, by Region, 2019-2032 (USD Billion)

9. Global Biomarker Discovery Outsourcing Services Market, by Geography

• 9.1. Key findings
• 9.2. Introduction
  • 9.2.1. Biomarker Discovery Outsourcing Services Market Assessment, By Geography, 2019-2032 (USD Billion)
• 9.3. Biomarker Discovery Outsourcing Services Market - North America
  • 9.3.1. North America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • 9.3.2. North America: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • 9.3.3. North America: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • 9.3.4. North America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 9.3.5. Biomarker Discovery Outsourcing Services Market - U.S.
    • 9.3.5.1. U.S.: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.3.5.2. U.S.: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.3.5.3. U.S.: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.3.5.4. U.S.: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 9.3.6. Biomarker Discovery Outsourcing Services Market - Canada
    • 9.3.6.1. Canada: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.3.6.2. Canada: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.3.6.3. Canada: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.3.6.4. Canada: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• 9.4. Biomarker Discovery Outsourcing Services Market - Europe
  • 9.4.1. Europe: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • 9.4.2. Europe: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • 9.4.3. Europe: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • 9.4.4. Europe: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 9.4.5. Biomarker Discovery Outsourcing Services Market - UK
    • 9.4.5.1. UK: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.4.5.2. UK: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.4.5.3. UK: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.4.5.4. UK: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 9.4.6. Biomarker Discovery Outsourcing Services Market - France
    • 9.4.6.1. France: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.4.6.2. France: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.4.6.3. France: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.4.6.4. France: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 9.4.7. Biomarker Discovery Outsourcing Services Market - Germany
    • 9.4.7.1. Germany: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.4.7.2. Germany: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.4.7.3. Germany: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.4.7.4. Germany: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 9.4.8. Biomarker Discovery Outsourcing Services Market - Italy
    • 9.4.8.1. Italy: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.4.8.2. Italy: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.4.8.3. Italy: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.4.8.4. Italy: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 9.4.9. Biomarker Discovery Outsourcing Services Market - Spain
    • 9.4.9.1. Spain: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.4.9.2. Spain: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.4.9.3. Spain: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.4.9.4. Spain: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 9.4.10. Biomarker Discovery Outsourcing Services Market - Netherlands
    • 9.4.10.1. Netherlands: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.4.10.2. Netherlands: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.4.10.3. Netherlands: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.4.10.4. Netherlands: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 9.4.11. Biomarker Discovery Outsourcing Services Market - Russia
    • 9.4.11.1. Russia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.4.11.2. Russia.: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.4.11.3. Russia: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.4.11.4. Russia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• 9.5. Biomarker Discovery Outsourcing Services Market - Asia Pacific
  • 9.5.1. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • 9.5.2. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • 9.5.3. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • 9.5.4. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 9.5.5. Biomarker Discovery Outsourcing Services Market - China
    • 9.5.5.1. China: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.5.5.2. China.: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.5.5.3. China: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.5.5.4. China: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 9.5.6. Biomarker Discovery Outsourcing Services Market - India
    • 9.5.6.1. India: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.5.6.2. India.: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.5.6.3. India: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.5.6.4. India: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 9.5.7. Biomarker Discovery Outsourcing Services Market - Japan
    • 9.5.7.1. Japan: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.5.7.2. Japan.: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.5.7.3. Japan: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.5.7.4. Japan: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 9.5.8. Biomarker Discovery Outsourcing Services Market - Malaysia
    • 9.5.8.1. Malaysia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.5.8.2. Malaysia.: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.5.8.3. Malaysia: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.5.8.4. Malaysia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 9.5.9. Biomarker Discovery Outsourcing Services Market - Indonesia
    • 9.5.9.1. Indonesia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.5.9.2. Indonesia.: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.5.9.3. Indonesia: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.5.9.4. Indonesia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 9.5.10. Biomarker Discovery Outsourcing Services Market - South Korea
    • 9.5.10.1. South Korea: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.5.10.2. South Korea.: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.5.10.3. South Korea: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.5.10.4. South Korea: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• 9.6. Biomarker Discovery Outsourcing Services Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • 9.6.2. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • 9.6.3. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • 9.6.4. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 9.6.5. Biomarker Discovery Outsourcing Services Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.6.5.2. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.6.5.3. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.6.5.4. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 9.6.6. Biomarker Discovery Outsourcing Services Market - South Africa
    • 9.6.6.1. South Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.6.6.2. South Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.6.6.3. South Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.6.6.4. South Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 9.6.7. Biomarker Discovery Outsourcing Services Market - Israel
    • 9.6.7.1. Israel: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.6.7.2. Israel: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.6.7.3. Israel: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.6.7.4. Israel: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 9.6.8. Biomarker Discovery Outsourcing Services Market - UAE
    • 9.6.8.1. UAE: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.6.8.2. UAE: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.6.8.3. UAE: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.6.8.4. UAE: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• 9.7. Biomarker Discovery Outsourcing Services Market - Latin America
  • 9.7.1. Latin America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
  • 9.7.2. Latin America: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
  • 9.7.3. Latin America: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
  • 9.7.4. Latin America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 9.7.5. Biomarker Discovery Outsourcing Services Market - Mexico
    • 9.7.5.1. Mexico: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.7.5.2. Mexico: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.7.5.3. Mexico: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.7.5.4. Mexico: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 9.7.6. Biomarker Discovery Outsourcing Services Market - Brazil
    • 9.7.6.1. Brazil: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.7.6.2. Brazil: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.7.6.3. Brazil: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.7.6.4. Brazil: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
  • 9.7.7. Biomarker Discovery Outsourcing Services Market - Argentina
    • 9.7.7.1. Argentina: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
    • 9.7.7.2. Argentina: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
    • 9.7.7.3. Argentina: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
    • 9.7.7.4. Argentina: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Laboratory Corporation of America Holdings
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Charles River Laboratories
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. Eurofins Scientific
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. Celerion
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. ICON plc
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. Parexel International (MA) Corporation
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. Proteome Sciences
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. GHO Capital
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. Thermo Fisher Scientific Inc.
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. Evotec
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development

List of Tables

• Table 1 Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, by Region, 2019-2032 (USD Billion)
• Table 2 Global Biomarker Discovery Outsourcing Services Market, by Type, by Region, 2019-2032 (USD Billion)
• Table 3 Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase, by Region, 2019-2032 (USD Billion)
• Table 4 Global Biomarker Discovery Outsourcing Services Market, by End Use, by Region, 2019-2032 (USD Billion)
• Table 5 Biomarker Discovery Outsourcing Services Market Assessment, By Geography, 2019-2032 (USD Billion)
• Table 6 North America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
• Table 7 North America: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
• Table 8 North America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• Table 9 North America: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
• Table 10 U.S.: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
• Table 11 U.S.: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
• Table 12 U.S.: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• Table 13 U.S.: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
• Table 14 Canada: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
• Table 15 Canada: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
• Table 16 Canada: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• Table 17 Canada: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
• Table 18 Europe: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
• Table 19 Europe: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
• Table 20 Europe: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• Table 21 Europe: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
• Table 22 Germany: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
• Table 23 Germany: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
• Table 24 Germany: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• Table 25 Germany: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
• Table 26 France: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
• Table 27 France: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
• Table 28 France: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• Table 29 France: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
• Table 30 UK: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
• Table 31 UK: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
• Table 32 UK: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• Table 33 UK: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
• Table 34 Italy: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
• Table 35 Italy: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
• Table 36 Italy: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• Table 37 Italy: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
• Table 38 Netherlands: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
• Table 39 Netherlands: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
• Table 40 Netherlands: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• Table 41 Netherlands: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
• Table 42 Spain: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
• Table 43 Spain: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
• Table 44 Spain: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• Table 45 Spain: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
• Table 46 Russia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
• Table 47 Russia: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
• Table 48 Russia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• Table 49 Russia: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
• Table 50 Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
• Table 51 Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
• Table 52 Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• Table 53 Asia Pacific: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
• Table 54 China: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
• Table 55 China: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
• Table 56 China: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• Table 57 China: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
• Table 58 Japan: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
• Table 59 Japan: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
• Table 60 Japan: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• Table 61 Japan: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
• Table 62 India: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
• Table 63 India: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
• Table 64 India: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• Table 65 India: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
• Table 66 Indonesia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
• Table 67 Indonesia: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
• Table 68 Indonesia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• Table 69 Indonesia: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
• Table 70 Malaysia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
• Table 71 Malaysia: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
• Table 72 Malaysia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• Table 73 Malaysia: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
• Table 74 South Korea: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
• Table 75 South Korea: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
• Table 76 South Korea: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• Table 77 South Korea: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
• Table 78 Latin America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
• Table 79 Latin America: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
• Table 80 Latin America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• Table 81 Latin America: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
• Table 82 Brazil: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
• Table 83 Brazil: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
• Table 84 Brazil: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• Table 85 Brazil: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
• Table 86 Mexico: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
• Table 87 Mexico: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
• Table 88 Mexico: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• Table 89 Mexico: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
• Table 90 Argentina: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
• Table 91 Argentina: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
• Table 92 Argentina: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• Table 93 Argentina: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
• Table 94 Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
• Table 95 Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
• Table 96 Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• Table 97 Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
• Table 98 UAE: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
• Table 99 UAE: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
• Table 100 UAE: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• Table 101 UAE: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
• Table 102 Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
• Table 103 Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
• Table 104 Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• Table 105 Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
• Table 106 South Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
• Table 107 South Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
• Table 108 South Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• Table 109 South Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)
• Table 110 Israel: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2019-2032 (USD Billion)
• Table 111 Israel: Biomarker Discovery Outsourcing Services Market, by Type, 2019-2032 (USD Billion)
• Table 112 Israel: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2019-2032 (USD Billion)
• Table 113 Israel: Biomarker Discovery Outsourcing Services Market, by End Use, 2019-2032 (USD Billion)

List of Figures

• Figure 1. Global Biomarker Discovery Outsourcing Services Market, 2019-2032 (USD Billion)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up End Use
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Therapeutic Area
• Figure 7. Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2021 & 2030 (USD Billion)
• Figure 8. Market by End Use
• Figure 9. Global Biomarker Discovery Outsourcing Services Market, by End Use, 2021 & 2030 (USD Billion)
• Figure 10. Market by Type
• Figure 11. Global Biomarker Discovery Outsourcing Services Market, by Type, 2021 & 2030 (USD Billion)
• Figure 12. Market by Discovery Phase
• Figure 13. Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2021 & 2030 (USD Billion)